Dynamic Monitoring of Gene Changes and Its Prognostic Value in Lung Cancer Patients

Background Targeted therapy, represented by epidermal growth factor receptor-targeting tyrosine kinase inhibitors (EGFR-TKIs) , has significantly prolonged the survival time of patients with EGFR mutations with relatively mild adverse reactions, and become a prior choice for advanced non-small cell...

Deskribapen osoa

Xehetasun bibliografikoak

Egile nagusia:	XUE Chongxiang, LU Xingyu, LIU Zhening, DONG Huijing, ZHENG Yumin, CUI Huijuan
Formatua:	Artigo
Hizkuntza:	Chinês
Argitaratua:	Chinese General Practice Publishing House Co., Ltd 2023-12-01
Saila:	Zhongguo quanke yixue
Gaiak:	lung neoplasms|epidermal growth factor|epidermal growth factor receptor inhibitor|genetic testing|tumor progression|mutation rules|survival follow-up|prognosis
Sarrera elektronikoa:	https://www.chinagp.net/fileup/1007-9572/PDF/20220833.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!